PDPN
Humans
Carcinoma, Squamous Cell
/ pathology
Cancer-Associated Fibroblasts
/ metabolism
Squamous Cell Carcinoma of Head and Neck
/ pathology
RNA, Long Noncoding
/ genetics
Mouth Neoplasms
/ pathology
Ferroptosis
/ genetics
Fibroblasts
/ metabolism
Head and Neck Neoplasms
/ metabolism
Tumor Microenvironment
Membrane Glycoproteins
/ metabolism
Journal
Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092
Informations de publication
Date de publication:
22 Nov 2023
22 Nov 2023
Historique:
received:
14
07
2023
accepted:
06
11
2023
revised:
28
10
2023
medline:
27
11
2023
pubmed:
23
11
2023
entrez:
22
11
2023
Statut:
epublish
Résumé
Cancer-associated fibroblasts (CAFs) are abundant and heterogeneous in tumor microenvironment (TME). Cross-talk between cancer cells and CAFs results in cancer progression. Here, we demonstrated that a distinct cancer-associated fibroblasts subset with podoplanin (PDPN) positive expression (PDPN
Identifiants
pubmed: 37993428
doi: 10.1038/s41419-023-06280-3
pii: 10.1038/s41419-023-06280-3
pmc: PMC10665425
doi:
Substances chimiques
RNA, Long Noncoding
0
PDPN protein, human
0
Membrane Glycoproteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
759Informations de copyright
© 2023. The Author(s).
Références
Clin Cancer Res. 2018 Oct 1;24(19):4808-4819
pubmed: 29914894
J Exp Clin Cancer Res. 2022 Jan 3;41(1):3
pubmed: 34980204
Neoplasia. 2021 Jul;23(7):692-703
pubmed: 34153644
Nature. 2020 Sep;585(7823):113-118
pubmed: 32814895
Cell. 2018 Feb 8;172(4):841-856.e16
pubmed: 29395328
Biochem Biophys Res Commun. 2014 Sep 26;452(3):490-6
pubmed: 25172658
Mol Cancer. 2013 Dec 20;12(1):168
pubmed: 24354864
Front Oncol. 2021 Mar 17;11:605884
pubmed: 33816238
RNA. 2019 Sep;25(9):1211-1217
pubmed: 31209064
Yonsei Med J. 2022 Mar;63(3):229-240
pubmed: 35184425
Theranostics. 2017 Aug 23;7(15):3700-3714
pubmed: 29109770
Front Oral Health. 2021 Jul 01;2:686337
pubmed: 35048030
EBioMedicine. 2018 Oct;36:209-220
pubmed: 30243489
Nat Commun. 2018 Dec 4;9(1):5150
pubmed: 30514914
Life Sci. 2020 Nov 1;260:118305
pubmed: 32827544
Cancers (Basel). 2022 Nov 29;14(23):
pubmed: 36497375
Cancer Res. 2011 Jul 15;71(14):4769-79
pubmed: 21610106
J Exp Clin Cancer Res. 2018 Oct 30;37(1):265
pubmed: 30376874
Cell Death Dis. 2020 Sep 11;11(9):743
pubmed: 32917852
Neoplasma. 2021 Jan;68(1):165-173
pubmed: 33038905
Biochim Biophys Acta. 2000 Apr 17;1496(2-3):333-40
pubmed: 10771101
Biosci Rep. 2013 Aug 30;33(4):
pubmed: 23875687
EBioMedicine. 2019 Jun;44:298-310
pubmed: 31201145
Cell Death Differ. 2019 Sep;26(9):1750-1765
pubmed: 30518908
Theranostics. 2018 Jun 24;8(14):3932-3948
pubmed: 30083271
Int J Cancer. 2015 Aug 15;137(4):784-96
pubmed: 25648219
Nat Cancer. 2020 Jul;1(7):692-708
pubmed: 35122040
Int J Cancer. 2008 Sep 1;123(5):1053-9
pubmed: 18546264
Am J Pathol. 2018 Jan;188(1):242-251
pubmed: 29037854
Mol Ther Nucleic Acids. 2020 Jun 01;22:319-328
pubmed: 33230437
Front Immunol. 2022 Jan 26;12:783362
pubmed: 35154072
Biomed Pharmacother. 2020 Jan;121:109623
pubmed: 31731187
Oncogene. 2017 Oct 12;36(41):5661-5667
pubmed: 28604750
Ann Transl Med. 2021 Sep;9(17):1369
pubmed: 34733921
Mol Cancer. 2015 Aug 14;14:155
pubmed: 26272696
Mol Oncol. 2014 Oct;8(7):1326-38
pubmed: 24880630
Biomed Pharmacother. 2022 Sep;153:113446
pubmed: 36076561
Cancer Res. 2017 Dec 1;77(23):6480-6488
pubmed: 29162616
Genes Dev. 2016 Apr 1;30(7):733-50
pubmed: 27036965
Cell. 2017 Oct 5;171(2):273-285
pubmed: 28985560
Evid Based Complement Alternat Med. 2022 May 29;2022:6177553
pubmed: 35677385
Cancer Res. 2020 Jun 1;80(11):2273-2285
pubmed: 32098781
Ecotoxicol Environ Saf. 2021 Sep 1;220:112376
pubmed: 34051661
Exp Cell Res. 2018 Aug 1;369(1):43-53
pubmed: 29719198
Cell Death Differ. 2019 Nov;26(11):2329-2343
pubmed: 30787392
Oncotarget. 2015 Apr 20;6(11):9531-41
pubmed: 25909164
Cell. 2012 May 25;149(5):1060-72
pubmed: 22632970